NEW YORK, USA, April 06, 2026 (GLOBE NEWSWIRE) -- Zion Market Research has published a new research report titled “Gastroenterology Products Market By Product Type (Endoscopy Devices, Laparoscopy Devices, GI Stents, Enteral Feeding Devices, Biopsy Devices, Hemostasis Devices, GI Imaging & Monitoring Systems, Pharmaceuticals & Biologics), By Disease Indication (Gastroesophageal Reflux Disease [GERD], Colorectal Cancer [CRC], Inflammatory Bowel Diseases [IBD] - Crohn’s disease, ulcerative colitis, Irritable Bowel Syndrome [IBS], Liver Disorders, Pancreatic Disorders, Biliary Diseases, Gastric & Peptic Ulcers, Others), By End-User (Hospitals & Clinics, Ambulatory Surgical Centers [ASCs], Diagnostic Centers, Research & Academic Institutes, and Home Healthcare), and By Region - Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, and Forecasts 2025 - 2034” in its research database.
“According to the latest research study, the global gastroenterology products market size was valued at around USD 5.15 billion in 2024. The market is expected to grow at a CAGR of 6.50% and is anticipated to reach a value of USD 9.66 billion by 2034.”
Get a Free Sample PDF of this Research Report for more Insights - https://www.zionmarketresearch.com/sample/gastroenterology-products-market
(Before you plan to buy, sample reports are a great option to examine our in-depth studies or reports)
Gastroenterology Products Industry Overview:
Gastroenterology products encompass a broad range of medical devices, instruments, and pharmaceuticals designed for the diagnosis, treatment, and management of disorders affecting the digestive system, including the esophagus, stomach, intestines, liver, pancreas, and biliary tract. These products include endoscopy systems for visualization and intervention, stents for maintaining patency, biopsy tools for tissue sampling, hemostasis devices for bleeding control, enteral feeding solutions, and various medications such as proton pump inhibitors and biologics for chronic conditions.
The market dynamics are shaped by robust growth from an aging global population and rising incidence of GI disorders, tempered by shortages of skilled professionals, while opportunities emerge from AI integration and non-invasive technologies, with challenges arising from regulatory hurdles and supply chain disruptions.
Report Scope:
| Report Attribute | Report Details |
| Market Size in 2024 | USD 5.15 Billion |
| Market Forecast in 2034 | USD 9.66 Billion |
| Growth Rate | CAGR of 6.50% |
| Base Year | 2024 |
| Forecast Years | 2025- 2034 |
| Key Companies Covered | Olympus Corporation, Medtronic plc, Boston Scientific Corporation, Johnson & Johnson (Ethicon), FUJIFILM Holdings Corporation, CONMED Corporation, Stryker Corporation, Pentax Medical (HOYA Group), B. Braun Melsungen AG, Cardinal Health Inc., Smith & Nephew plc, KARL STORZ SE & Co. KG, Alvimedica, EndoChoice Holdings Inc., ERBE Elektromedizin GmbH, and others. |
| Segments Covered | By Product Type, By Disease Indication, By End-User, and By Region |
| Regions Covered | North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa |
| Customization Scope | Avail customized purchase options to meet your exact research needs. |
Directly Purchase a Copy of the Report | Quick Delivery Available - https://www.zionmarketresearch.com/buynow/su/gastroenterology-products-market
Key Insights
Industry Growth Factors
Growth Drivers
What are the primary growth drivers for the Gastroenterology Products Market?
The growing aging population worldwide significantly increases the incidence of gastrointestinal disorders such as GERD, colorectal cancer, and inflammatory bowel diseases, creating sustained demand for advanced diagnostic devices, therapeutic instruments, and pharmaceuticals tailored to age-related digestive health challenges.
Technological advancements in endoscopy, including high-definition imaging, 3D visualization, AI-based lesion detection, and capsule endoscopy, alongside the shift toward minimally invasive procedures, enhance diagnostic accuracy, reduce recovery times, and improve patient outcomes, encouraging wider adoption across hospitals and specialty clinics.
Restraints
What factors are restraining the growth of the Gastroenterology Products Market?
The limited availability of skilled gastroenterologists and trained technicians, particularly in developing and rural regions, restricts the effective utilization of sophisticated equipment and slows the pace of procedure volumes despite technological progress.
Stringent regulatory approval processes from bodies such as the FDA and EMA, combined with lengthy review timelines for new devices and biologics, delay market entry of innovative products and increase development costs for manufacturers.
Browse the full “Gastroenterology Products Market - Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, and Forecasts 2025 - 2034” Report at https://www.zionmarketresearch.com/report/gastroenterology-products-market
Gastroenterology Products Market: Segmentation
The gastroenterology products market is segmented by product type, disease indication, end-user, and region.
Based on Product Type Segment, the gastroenterology products market is divided into endoscopy devices, laparoscopy devices, GI stents, enteral feeding devices, biopsy devices, hemostasis devices, GI imaging & monitoring systems, and pharmaceuticals & biologics. The endoscopy devices segment is the most dominant with the largest share because of its central role in both diagnosis and therapeutic interventions for a broad spectrum of GI conditions, enhanced by innovations in AI-assisted detection and high-definition imaging that boost procedural efficiency and support preventive screening, directly driving overall market growth; the pharmaceuticals & biologics segment ranks as the second most dominant with considerable growth potential as targeted therapies for chronic conditions like IBD and GERD gain traction through personalized medicine approaches.
Based on Disease Indication Segment, the gastroenterology products market is divided into gastroesophageal reflux disease (GERD), colorectal cancer (CRC), inflammatory bowel diseases (IBD), irritable bowel syndrome (IBS), liver disorders, pancreatic disorders, biliary diseases, gastric & peptic ulcers, and others. The gastroesophageal reflux disease (GERD) segment is the most dominant with the largest share due to its widespread prevalence affecting millions globally, chronic management requirements involving diagnostics, medications, and endoscopic treatments, and growing public awareness campaigns that promote early intervention; the colorectal cancer (CRC) segment ranks as the second most dominant with substantial revenue growth prospects driven by national screening programs and demand for advanced biopsy, imaging, and therapeutic devices.
Based on End-User Segment, the gastroenterology products market is divided into hospitals & clinics, ambulatory surgical centers (ASCs), diagnostic centers, research & academic institutes, and home healthcare. The hospitals & clinics segment is the most dominant with the leading share because they provide comprehensive GI care with access to advanced equipment, multidisciplinary teams, and high patient throughput, enabling efficient use of endoscopy systems, stents, and biologics while supporting complex procedures; the ambulatory surgical centers (ASCs) segment ranks as the second most dominant with growing adoption due to the shift toward outpatient minimally invasive interventions that reduce costs and recovery times.
Recent Developments
Regional Scope:
Why will North America continue to dominate the global market during the projection period?
North America continues to lead the global gastroenterology products market, driven by the high prevalence of gastrointestinal disorders, including GERD, colorectal cancer, and IBD, and by a well-established healthcare infrastructure featuring modern hospitals, specialty clinics, and diagnostic centers equipped with state-of-the-art endoscopic and imaging technologies. The United States serves as the primary driver with significant investments in advanced AI-assisted endoscopy systems, capsule endoscopy, and minimally invasive tools that support early detection and treatment. A rapidly aging population further elevates demand for chronic disease management products and preventive screening programs. Strong regulatory support and reimbursement frameworks encourage the adoption of innovative devices and biologics. Collaborative research initiatives between manufacturers, academic institutions, and healthcare providers accelerate the development and integration of next-generation solutions. Public awareness campaigns and digital health initiatives promote proactive GI care across diverse demographics.
Europe holds the second-leading position, supported by sophisticated healthcare systems and a large elderly population prone to digestive disorders. Countries emphasize high-quality endoscopic procedures and advanced imaging for accurate diagnosis.
Asia Pacific exhibits rapid growth driven by expanding healthcare infrastructure, rising awareness of GI health, and increasing adoption of minimally invasive technologies in urban centers.
Gastroenterology Products Market: Competitive Landscape
The report contains qualitative and quantitative research on the global gastroenterology products market, as well as detailed insights and development strategies employed by the leading competitors.
Some of the main players in the global gastroenterology products market include;
The global gastroenterology products market is segmented as follows:
By Product Type
By Disease Indication
By End-User
By Region
Key Questions Answered in This Report:
Key Offerings:
Browse Other Related Research Reports
About Zion Market Research:
Zion Market Research is a leading market research organization offering industry expertise and scrupulous consulting services to clients for their business development. The reports and services offered by Zion Market Research are used by prestigious academic institutions, start-ups, and companies globally to measure and understand the changing international and regional business backgrounds.
Contact Us:
Zion Market Research
USA/Canada Toll Free: 1 (855) 465-4651 | Newark: 1 (302) 444-0166
India: +91 7768 006 007 | +91 7768 006 008